Cargando…
A new anti-glioma therapy, AG119: pre-clinical assessment in a mouse GL261 glioma model
BACKGROUND: High grade gliomas (HGGs; grades III and IV) are the most common primary brain tumors in adults, and their malignant nature ranks them fourth in incidence of cancer death. Standard treatment for glioblastomas (GBM), involving surgical resection followed by radiation and chemotherapy with...
Autores principales: | Towner, Rheal A., Ihnat, Michael, Saunders, Debra, Bastian, Anja, Smith, Nataliya, Pavana, Roheeth Kumar, Gangjee, Aleem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504175/ https://www.ncbi.nlm.nih.gov/pubmed/26177924 http://dx.doi.org/10.1186/s12885-015-1538-9 |
Ejemplares similares
-
AG488 as a therapy against gliomas
por: Ziegler, Jadith, et al.
Publicado: (2017) -
Anthracycline-induced cytotoxicity in the GL261 glioma model system
por: Tavener, Amber M., et al.
Publicado: (2021) -
A therapeutic cancer vaccine against GL261 murine glioma
por: Kindy, Mark S., et al.
Publicado: (2016) -
Perfluorocarbon emulsions radiosensitise brain tumors in carbogen breathing mice with orthotopic GL261 gliomas
por: Feldman, Lisa A., et al.
Publicado: (2017) -
Temporal and spatial modulation of the tumor and systemic immune response in the murine Gl261 glioma model
por: McKelvey, Kelly J., et al.
Publicado: (2020)